In the last 12 months, insiders at Indaptus Therapeutics, Inc. ($INDP) filed 76 transactions with the SEC: 0 open-market purchases totaling $0 and 2 sales totaling $0. Net insider sentiment: neutral.
Indaptus Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Meckler Jeffrey A (Co-Chief Executive Officer) — 7 transactions totaling $439,733
- Meckler Jeffrey A (CEO and Director) — 6 transactions totaling $205,004
- Linscott Walt Addison (Chief Operating Officer) — 9 transactions totaling $110,475
- Newman Michael James (CSO and Director) — 3 transactions totaling $105,974
- Sassi Nir (Chief Financial Officer) — 10 transactions totaling $54,319
View all SEC Filings for Indaptus Therapeutics, Inc. (INDP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Lazar David E. | Director | S | Series AA Convertible Non-Redeemable Preferred Stock | 196800 | $0.00 | 103,200.0000 | 1,641,920 | 65.60% | 11.99% |
| March 23, 2026 | Lazar David E. | Director | S | Series AAA Convertible Non-Redeemable Preferred Stock | 700000 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 42.63% |
| Feb. 26, 2026 | Jabbour Jerome D | Director | A | Option to Buy Common Stock | 25000 | $0.00 | 25,000.0000 | 1,641,920 | 9999.99% | 1.52% |
| Feb. 11, 2026 | Meckler Jeffrey A | Co-Chief Executive Officer | D | Warrants (right to buy) | 1519 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 0.09% |
| Feb. 11, 2026 | Meckler Jeffrey A | Co-Chief Executive Officer | A | Warrants (right to buy) | 12136 | $0.00 | 12,136.0000 | 1,641,920 | 9999.99% | 0.74% |
| Feb. 11, 2026 | Meckler Jeffrey A | Co-Chief Executive Officer | D | Warrants (right to buy) | 12136 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 0.74% |
| Feb. 11, 2026 | Meckler Jeffrey A | Co-Chief Executive Officer | A | Warrants (right to buy) | 1519 | $0.00 | 1,519.0000 | 1,641,920 | 9999.99% | 0.09% |
| Feb. 11, 2026 | Meckler Jeffrey A | Co-Chief Executive Officer | A | Warrants (right to buy) | 3033 | $0.00 | 3,033.0000 | 1,641,920 | 9999.99% | 0.18% |
| Feb. 11, 2026 | Meckler Jeffrey A | Co-Chief Executive Officer | D | Warrants (right to buy) | 3033 | $0.00 | 0.0000 | 1,641,920 | 100.00% | 0.18% |
| Jan. 20, 2026 | Ben-Tzvi Avraham | Director | A | Common Stock | 25000 | $0.00 | 25,100.0000 | 1,641,920 | 9999.99% | 1.52% |
| Dec. 23, 2025 | Ben-Tzvi Avraham | Director | A | Option to Buy Common Stock | 25000 | $0.00 | 25,000.0000 | 1,641,920 | 9999.99% | 1.52% |
| Jan. 7, 2026 | NATAN DAVID | Director | A | Option to Buy Common Stock | 25000 | $0.00 | 25,000.0000 | 1,641,920 | 9999.99% | 1.52% |
| Dec. 22, 2025 | Newman Michael James | CSO and Director | A | Common Stock | 52204 | $2.03 | 101,074.0000 | 1,641,920 | 106.82% | 3.18% |
| Dec. 22, 2025 | Meckler Jeffrey A | Co-Chief Executive Officer | A | Common Stock | 216617 | $2.03 | 229,929.0000 | 1,641,920 | 1627.23% | 13.19% |
| Dec. 22, 2025 | Sassi Nir | Chief Financial Officer | A | Common Stock | 26758 | $2.03 | 26,758.0000 | 1,641,920 | 9999.99% | 1.63% |
| Dec. 22, 2025 | Linscott Walt Addison | Chief Operating Officer | A | Common Stock | 54421 | $2.03 | 54,426.0000 | 1,641,920 | 9999.99% | 3.31% |
| July 27, 2025 | Meckler Jeffrey A | Chief Executive Officer | A | Common Stock | 6068 | $8.30 | 13,312.0000 | 604,963 | 83.77% | 1.00% |
| July 27, 2025 | Meckler Jeffrey A | Chief Executive Officer | A | Common Stock Warrants | 12136 | $8.30 | 16,688.0000 | 604,963 | 266.61% | 2.01% |
| June 10, 2025 | Pomerantz Roger | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 12,013,901 | 9999.99% | 0.25% |
| June 10, 2025 | Gilbert Mark John | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,013,901 | 9999.99% | 0.10% |
| June 10, 2025 | Karah Hila | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,013,901 | 9999.99% | 0.10% |
| June 10, 2025 | MADDALUNA ANTHONY J | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,013,901 | 9999.99% | 0.10% |
| June 10, 2025 | Hayes William B | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,013,901 | 9999.99% | 0.10% |
| June 10, 2025 | Martell Robert | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 12,013,901 | 9999.99% | 0.10% |
| April 10, 2025 | MADDALUNA ANTHONY J | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Karah Hila | Director | D | Stock Option (right to buy) | 500 | $0.39 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Karah Hila | Director | D | Stock Option (right to buy) | 250 | $0.39 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Karah Hila | Director | D | Stock Option (right to buy) | 281 | $0.39 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Karah Hila | Director | D | Stock Option (right to buy) | 250 | $0.39 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Hayes William B | Director | D | Stock Option (right to buy) | 500 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Hayes William B | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Hayes William B | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 1250 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 1250 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 1125 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 2500 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.02% |
| April 10, 2025 | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 500 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 500 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 41 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Sassi Nir | Chief Financial Officer | D | Stock Option (right to buy) | 1125 | $0.07 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Linscott Walt Addison | Chief Operating Officer | D | Stock Option (right to buy) | 1750 | $0.06 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Linscott Walt Addison | Chief Operating Officer | D | Stock Option (right to buy) | 750 | $0.06 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Linscott Walt Addison | Chief Operating Officer | D | Stock Option (right to buy) | 1250 | $0.06 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Linscott Walt Addison | Chief Operating Officer | D | Stock Option (right to buy) | 1125 | $0.06 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Linscott Walt Addison | Chief Operating Officer | D | Stock Option (right to buy) | 2500 | $0.06 | 0.0000 | 12,013,901 | 100.00% | 0.02% |
| April 10, 2025 | Linscott Walt Addison | Chief Operating Officer | D | Stock Option (right to buy) | 1125 | $0.06 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Pomerantz Roger | Director | D | Stock Option (right to buy) | 500 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Pomerantz Roger | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Pomerantz Roger | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 4750 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.04% |
| April 10, 2025 | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 3750 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.03% |
| April 10, 2025 | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 813 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Meckler Jeffrey A | Chief Executive Officer | D | sStock Option (right to buy) | 1500 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | Meckler Jeffrey A | Chief Executive Officer | D | Stock Option (right to buy) | 1563 | $0.04 | 0.0000 | 12,013,901 | 100.00% | 0.01% |
| April 10, 2025 | MADDALUNA ANTHONY J | Director | D | Stock Option (right to buy) | 500 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| April 10, 2025 | MADDALUNA ANTHONY J | Director | D | Stock Option (right to buy) | 250 | $0.50 | 0.0000 | 12,013,901 | 100.00% | 0.00% |
| Nov. 25, 2024 | Meckler Jeffrey A | CEO and Director | A | Common stock | 42553 | $1.18 | 202,859.0000 | 8,401,047 | 26.54% | 0.51% |
| Nov. 25, 2024 | Meckler Jeffrey A | CEO and Director | A | Common Stock Warrants | 42553 | $1.18 | 42,553.0000 | 8,401,047 | 9999.99% | 0.51% |
| Oct. 9, 2024 | Meckler Jeffrey A | CEO and Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Oct. 9, 2024 | Linscott Walt Addison | Chief Operating Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Oct. 9, 2024 | Sassi Nir | Chief Financial Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Oct. 9, 2024 | Waltzman Roger J. | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Oct. 9, 2024 | Newman Michael James | CSO and Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Aug. 8, 2024 | Meckler Jeffrey A | CEO and Director | A | Common Stock Warrants | 84932 | $1.83 | 84,932.0000 | 8,401,047 | 9999.99% | 1.01% |
| Aug. 8, 2024 | Meckler Jeffrey A | CEO and Director | A | Common stock | 84932 | $1.83 | 160,306.0000 | 8,401,047 | 112.68% | 1.01% |
| June 6, 2024 | Karah Hila | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 8,401,047 | 9999.99% | 0.15% |
| June 6, 2024 | Hayes William B | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 8,401,047 | 9999.99% | 0.15% |
| June 6, 2024 | Martell Robert | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 8,401,047 | 9999.99% | 0.15% |
| June 6, 2024 | MADDALUNA ANTHONY J | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 8,401,047 | 9999.99% | 0.15% |
| June 6, 2024 | Pomerantz Roger | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,401,047 | 9999.99% | 0.36% |
| June 6, 2024 | Gilbert Mark John | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 8,401,047 | 9999.99% | 0.15% |
| Jan. 22, 2024 | Waltzman Roger J. | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Jan. 22, 2024 | Linscott Walt Addison | Chief Operating Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 8,401,047 | 9999.99% | 0.89% |
| Jan. 22, 2024 | Newman Michael James | CSO and Director | A | Stock Option (Right to Buy) | 43250 | $0.00 | 43,250.0000 | 8,401,047 | 9999.99% | 0.51% |
| Jan. 22, 2024 | Meckler Jeffrey A | CEO and Director | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 8,401,047 | 9999.99% | 1.19% |
| Jan. 22, 2024 | Sassi Nir | Chief Financial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 8,401,047 | 9999.99% | 0.48% |